Kelsey Bauman

Recommended Articles

• Parkinson's Disease Patients are Given Renewed Hope with a New Therapy

  Hitherto there is no truly preventive treatment for Parkinson’s disease. It is important that neurologists be aware of the symptomatic triad of depression, losing the sense of smell and constipation. It is good to consult with a neurologist with some expertise in the subject when these cases are...

• The Lesser Known Symptoms of Lupus

  Lupus, which means wolf in Latin, is as strange, unpredictable, and mysterious as its name. It is not a name for one single disease. With the name lupus, it could mean four diseases which are systemic lupus, cutaneous lupus, drug-induced lupus, and neonatal lupus. Out of all of them, systemic lupus...

• Treatment Options of Multiple Myeloma

  A team led by a consultant haematology specialist takes care of you if you are a multiple myeloma patient. The team discusses your situation and suggests the best treatment for you, but you will finally decide.It may be paramount to compile a list of questions which you will ask the specialist...

• Nonsteroidal Anti-Inflammatory Drugs for Crohn's

  Pain management can be considered a treatment plan that the patient and doctor can design together. The effective way of controlling pain can be through taking the drugs for Crohn’s disease as per the doctor’s prescription. The treatment plan may involve various medicines to reduce the pain...

• Polydipsia: Excessive Thirst Causes and Symptoms

  What is polydipsia?Polydipsia is the medical term for excessive thirst. It is usually regarded as one of the initial symptoms of diabetes.It is normal to feel thirsty, especially after workouts and strenuous activities. It is quite important for people to drink the recommended amount of water per...

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...